Mørch, Kristine
Chiodini, Peter
Nabarro, Laura
Hannula, Raisa
Neumayr, Andreas
Haanshuus, Christel Gill
Saghaug, Christina
Blomberg, Bjørn
Pettersen, Frank Olav Dahler
Sandnes, Helene Heitmann
Hanevik, Kurt
Langeland, Nina
Funding for this research was provided by:
University of Bergen
Article History
Received: 10 February 2026
Accepted: 15 June 2026
First Online: 20 June 2026
Declarations
Ethics approval and consent to participate: Written informed consent was obtained from the patients. The patients were informed about the treatment and potential side effects and were treated and monitored according to clinical practice. The study was approved by the Regional Ethics Committees in Norway (2013/1285/REK vest), England (IRAS 228,436 – REC 18/NW/0630) and Switzerland (Ethics Commission Northwest and Central Switzerland - Ref Nr. 2014–112). The study was carried out in accordance with the Declaration of Helsinki.
Consent for publication: Not applicable.
Competing interests: The authors declare no competing interests.